 |
 |
|
Mr.
McInerney is a Principal at Two River and a Partner
of Riverbank Capital Securities, Inc. From 1992 to
March 2007, Mr. McInerney was a Managing Director of
Paramount BioCapital, Inc. where he oversaw the
overall distribution of Paramount’s private equity
product. Prior to 1992, Mr. McInerney was a research
analyst focusing on the biotechnology industry at
Ladenburg, Thalman & Co. Prior to that, Mr.
McInerney held equity sales positions at Bear
Stearns & Co. and Shearson Lehman Brothers, Inc. Mr.
McInerney also worked in sales and marketing for
Bristol-Myers Squibb. Mr. McInerney currently serves
on the board of directors of a number of
biotechnology companies including ZIOPHARM, Inc.,
Insite Vision, Inc., and Edgemont Pharmaceuticals,
LLC. He received his B.S. in pharmacy from St. John’s
University at New York. He also completed a
post-graduate residency at the New York University
Medical Center in drug information systems. |
|
|
|
|
